Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Geraci

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Proceedings of the American Thoracic Society|January 5, 2007
Gene expression profiling in pulmonary hypertensionTodd M Bull, Christopher D Coldren, Mark W Geraci, et al.
Chest|December 24, 2005
The expression of prostacyclin synthase is decreased in the small pulmonary arteries from patients with emphysemaJong Deog Lee, Laima Taraseviciene-Stewart, Robert Keith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2009
Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent mannerDerek Strassheim, Suzzette R Riddle, Danielle L Burke, et al.
Free Radical Biology & Medicine|May 16, 2012
Promoter G-quadruplex sequences are targets for base oxidation and strand cleavage during hypoxia-induced transcriptionDavid W Clark, Tzu Phang, Michael G Edwards, et al.
Chest|March 15, 2002
Overexpression of matrix metalloproteinase-7 in pulmonary fibrosisGregory P Cosgrove, Marvin I Schwarz, Mark W Geraci, et al.
Cancer Research|January 4, 2008
A macrophage gene expression signature defines a field effect in the lung tumor microenvironmentRobert S Stearman, Lori Dwyer-Nield, Michael C Grady, et al.
Molecular Cancer Research : MCR|March 22, 2007
Genetic and epigenetic regulation of the human prostacyclin synthase promoter in lung cancer cell linesRobert S Stearman, Michael C Grady, Patrick Nana-Sinkam, et al.
Oncogene|December 21, 2004
Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC)Yvette Bren-Mattison, Vicki Van Putten, Daniel Chan, et al.
International Journal of Molecular Sciences|November 13, 2021
Low-Coverage Whole Genome Sequencing Using Laser Capture Microscopy with Combined Digital Droplet PCR: An Effective Tool to Study Copy Number and Kras Mutations in Early Lung Adenocarcinoma DevelopmentElizabeth A Mickler, Huaxin Zhou, Tzu L Phang, et al.
Chest|March 15, 2002
Gene expression profiles in pulmonary hypertensionMark W Geraci, Yasushi Hoshikawa, Michael Yeager, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Proceedings of the American Thoracic Society|January 5, 2007
Gene expression profiling in pulmonary hypertensionTodd M Bull, Christopher D Coldren, Mark W Geraci, et al.
Chest|December 24, 2005
The expression of prostacyclin synthase is decreased in the small pulmonary arteries from patients with emphysemaJong Deog Lee, Laima Taraseviciene-Stewart, Robert Keith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2009
Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent mannerDerek Strassheim, Suzzette R Riddle, Danielle L Burke, et al.
Free Radical Biology & Medicine|May 16, 2012
Promoter G-quadruplex sequences are targets for base oxidation and strand cleavage during hypoxia-induced transcriptionDavid W Clark, Tzu Phang, Michael G Edwards, et al.
Chest|March 15, 2002
Overexpression of matrix metalloproteinase-7 in pulmonary fibrosisGregory P Cosgrove, Marvin I Schwarz, Mark W Geraci, et al.
Cancer Research|January 4, 2008
A macrophage gene expression signature defines a field effect in the lung tumor microenvironmentRobert S Stearman, Lori Dwyer-Nield, Michael C Grady, et al.
Molecular Cancer Research : MCR|March 22, 2007
Genetic and epigenetic regulation of the human prostacyclin synthase promoter in lung cancer cell linesRobert S Stearman, Michael C Grady, Patrick Nana-Sinkam, et al.
Oncogene|December 21, 2004
Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC)Yvette Bren-Mattison, Vicki Van Putten, Daniel Chan, et al.
International Journal of Molecular Sciences|November 13, 2021
Low-Coverage Whole Genome Sequencing Using Laser Capture Microscopy with Combined Digital Droplet PCR: An Effective Tool to Study Copy Number and Kras Mutations in Early Lung Adenocarcinoma DevelopmentElizabeth A Mickler, Huaxin Zhou, Tzu L Phang, et al.
Chest|March 15, 2002
Gene expression profiles in pulmonary hypertensionMark W Geraci, Yasushi Hoshikawa, Michael Yeager, et al.
Pageof 10